Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.855 -0.665 (-6.99%)
Streaming Delayed Price Updated: 1:40 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
64 65 Next >
Why Are There So Many Sellers Of Novavax Stock Today?
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday morning after the company announced a proposed public offering and a 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
Why Shares of Novavax Are Down Tuesday
A disagreement over a contract sent the stock tumbling. 
Via The Motley Fool
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. 
Via Benzinga
Nasdaq, S&P Futures Plunge As Fed's Hawkish Tone Deflates Risk Appetite: Retail Sales, Manufacturing Data, Tesla, Novavax In Focus
Stocks look set to start Thursday’s session notably lower as traders are left to ponder the hawkish tone orchestrated by the Federal Reserve. 
Via Benzinga
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Each of these companies hit rough patches this year. 
Via The Motley Fool
Tesla, Amazon, Novavax, Lennar Corp, Avidity Biosciences: Why These 5 Stocks Are Drawing Retail Investors' Attention Today
Major Wall Street indices closed in the red on Wednesday despite an anticipated 50 basis points hike by the Federal Reserve as Chair Jerome Powell indicated the need for more data before the central... 
Via Benzinga
Novavax Stock Is Diving After Hours: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are trading lower in Wednesday's after-hours session after the company announced a  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down 86% to 95% That Can Double Your Money in 2023
A peak 38% decline in the Nasdaq Composite has set these innovative growth stocks up for a bounce-back year. 
Via The Motley Fool
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
 
Via Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health... 
Via Benzinga
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street
Select Wall Street analysts believe these fast-growing companies could skyrocket next year. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies hit new 52-week lows. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
What's Going On With Novavax Stock?
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday after the company announced the World Health Organization (WHO) issued an updated Emergency Use Listing for its Nuvaxovid vaccine as a... 
Via Benzinga
Is Novavax Stock a Buy Now?
There's probably not much good news coming for this biotech in the near future. 
Via The Motley Fool
3 Potentially Explosive Stocks to Buy Before 2023
These stocks suffered in 2022. And they have reason to rebound. 
Via The Motley Fool
Novavax Stock: Buy, Sell, or Hold in 2023?
The shares are heading for almost a 90% loss this year. 
Via The Motley Fool
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
Via Benzinga
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi
Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session. 
Via InvestorPlace
Jack Ma's Ant Group Slapped With $1B Fine, Carl Icahn's Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22
Reuters 
Via Benzinga
Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines
Novavax Inc (NASDAQ: NVAX) delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19 vaccine to low- and middle-income... 
Via Benzinga
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025
These beaten-down innovators have industry-changing potential. 
Via The Motley Fool
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19. 
Via InvestorPlace
Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults
Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older. 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS